Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
Tariffs Turn Ikea’s “Low Price” Promise Upside Down
IKEA is being forced to raise prices on some furniture in the U.S. as Trump‑era tariffs raise import costs.
Driverless Delivery Hits the Streets of Phoenix
Waymo and DoorDash are teaming up to pilot autonomous delivery in Phoenix, using Waymo’s self‑driving Jaguars to drop off DoorDash orders.
Trump and Putin to Meet in Hungary to Discuss Ukraine War
President Trump announced that he and Russian President Vladimir Putin agreed to meet in Budapest to discuss ending the war in Ukraine.
Spooked Spenders? Why Halloween Shoppers May or May Not Be Holding Back
Katie Thomas of Kearney Consumer Institute explains why inflation, timing, and habits aren't getting in the way of consumerism this Halloween.
The Coolest Gadgets, Breakthroughs, and Life-Changers of 2025, According to TIME
TIME’s Emma Barker joins to reveal the 25th annual Best Inventions list — highlighting the most groundbreaking, life-changing innovations of 2025.
How Smarsh Stays Ahead in Technology and Leadership
Smarsh CEO Kim Crawford Goodman talks about the company's mission to protect the truth. *Sponsored by Smarsh
